Items where authors include "Dehbi, H-M."

Article

Dehbi, H-M., Mallick, U., Wadsley, J. et al. (3 more authors) (2019) Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial. Lancet Diabetes and Endocrinology, 7 (1). pp. 44-51. ISSN 2213-8587

Seddon, B., Strauss, S.J., Whelan, J. et al. (16 more authors) (2017) Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. The Lancet Oncology, 18 (10). pp. 1397-1410. ISSN 1470-2045